Humacyte/$HUMA
About Humacyte
Ticker
Industry
Employees
Humacyte Metrics
$504M
-
-$1.36
1.47
-
Price and volume
Market cap
$504M
Beta
1.47
52-week high
$9.97
52-week low
$2.81
Average daily volume
2.3M
Financial strength
Current ratio
1.099
Quick ratio
0.982
Long term debt to equity
-120.442
Total debt to equity
-124.974
Interest coverage (TTM)
-13.24%
Management effectiveness
Return on assets (TTM)
-53.23%
Return on equity (TTM)
1,143.87%
Valuation
Price to book
-7.37
Price to tangible book (TTM)
-7.37
Price to free cash flow (TTM)
-4.785
Growth
Earnings per share change (TTM)
56.87%
3-year earnings per share growth (CAGR)
-37.29%
What the Analysts think about Humacyte
Analyst Ratings
Humacyte Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Humacyte Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Humacyte News

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

January 17, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against HUMA
What’s the current market cap for Humacyte stock?
What is the P/E ratio for Humacyte stock?
Does Humacyte stock pay dividends?
No, Humacyte (HUMA) stock does not pay dividends to its shareholders as of February 14, 2025.
When is the next Humacyte dividend payment date?
Humacyte (HUMA) stock does not pay dividends to its shareholders.
What is the beta indicator for Humacyte?
Humacyte (HUMA) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.